COMMUNIQUÉS West-GlobeNewswire

UPDATED MEDIA ADVISORY: Updated list of Public Hearings re. Public Hearings across Ontario to protect & restore local public hospitals
10/06/2024
TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- In response to more than 1,200 closures of emergency departments and other local hospital services over the last year , the Ontario Health Coalition (OHC) is holding public [...]
Partnership of Spineway with the SFCR for June 24 congress
10/06/2024
Press release Ecully, June 10, 2024 – 6 p.m. SPINEWAY partners with the Société Française de Chirurgie du Rachis (SFCR) Congress in Montpellier, France The Spineway Group, a specialist in innovative implants for the [...]
SPINEWAY partenaire de la SFCR lors du congrès de Juin 2024
10/06/2024
Communiqué de presse Ecully, le 10 juin 2024 – 18h SPINEWAY sera partenaire du congrès de la Société Française de Chirurgie du Rachis (SFCR) à Montpellier Le groupe Spineway spécialiste des implants innovants pour le [...]
Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.
10/06/2024
Stocking of GLOPERBA ® is underway in all of the wholesalers with which Scilex has stocking arrangements throughout the U.S and Scilex expects completion of stocking by Wednesday June 12, 2024. Today, Scilex is [...]
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE
10/06/2024
Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel [...]
Transactions in Connection with Share Buy-back Program
10/06/2024
Company Announcement COPENHAGEN, Denmark; June 10, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. [...]
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
10/06/2024
Westport, CT, June 10, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]
Palisade Bio to Present at the Virtual Investor Pitch Conference
10/06/2024
Live video webcast on Monday, June 17 th at 12:00 PM ET Carlsbad, CA, June 10, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing [...]
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association
10/06/2024
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable [...]
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
10/06/2024
ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA SAN DIEGO, June 10, [...]
TOMI Environmental Solutions Secures Two New Purchase Agreements with Leading Pharmaceutical Companies
10/06/2024
FREDERICK, Md., June 10, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization [...]
TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary
10/06/2024
Prime location features a convenient drive-thru and an expanded floor plan TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American [...]
SFWJ/MedCana Announces Significant Progress Across Its Operations, Eyes Global Expansion and Enhanced Profitability
10/06/2024
AUSTIN, Texas, June 10, 2024 (GLOBE NEWSWIRE) -- via IBN – SFWJ, doing business as MedCana, a leading entity in the cannabis and agricultural technology sectors, unveils its strategic initiative as the Company embarks [...]
Longeveron to Present at the Emerging Growth Virtual Conference on June 12, 2024
10/06/2024
MIAMI, June 10, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Emerging Growth Virtual [...]
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
10/06/2024
Live video webcast on Monday, June 17th at 1:00 PM ET OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief [...]
SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r/r AML
10/06/2024
- 30 Patients Relapsed or Refractory to Venetoclax-Based Regimens Enrolled Ahead of Schedule - - Overall Response Rate (ORR) of 33% and 50% Achieved to Date in 60 mg QW and 30 mg BIW Cohorts, Respectively - - 45 mg ( [...]
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
10/06/2024
SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in preclinical models Treatment with SZN-043 in the Phase 1a trial was safe and well tolerated in healthy [...]
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona
10/06/2024
June 10, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 [...]
Veru to Present at the American Diabetes Association's 84th Scientific Sessions
10/06/2024
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]

Pages